- Conditions
- Grass Allergy, Rhinoconjunctivitis
- Interventions
- Not listed
- Lead sponsor
- Circassia Limited
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 5
- States / cities
- Washington D.C., District of Columbia • Normal, Illinois • Sylvania, Ohio + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 26
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo (0.5ml), Placebo (1.0ml), Grass MATA MPL (0.5ml) 5100SU, Grass MATA MPL (1.0ml) 10200SU, Grass MATA MPL (1.0ml) 18200SU, Grass MATA (0.5ml) 5100SU
- Biological
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 265 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Neptune City, New Jersey
- Conditions
- Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite
- Interventions
- Sublingual allergy immunotherapy tablet, Placebo
- Biological · Other
- Lead sponsor
- ALK-Abelló A/S
- Industry
- Eligibility
- 5 Years to 11 Years
- Enrollment
- 1,460 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 29
- States / cities
- Huntington Beach, California • Los Angeles, California • San Diego, California + 25 more
- Conditions
- Seasonal Allergic Rhinitis, Rhinoconjunctivitis
- Interventions
- PQ Grass, Placebo
- Biological
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 555 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 33
- States / cities
- Centennial, Colorado • Denver, Colorado • Lexington, Kentucky + 27 more
- Conditions
- Allergic Rhinitis, Allergic Rhinoconjunctivitis
- Interventions
- Norketotifen, Placebo
- Drug
- Lead sponsor
- Emergo Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Healthy, Allergy, Allergic Rhinoconjunctivitis
- Interventions
- Thermography
- Procedure
- Lead sponsor
- West Penn Allegheny Health System
- Other
- Eligibility
- 7 Years to 70 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Rhinoconjunctivitis
- Interventions
- Cat-PAD, Placebo
- Drug
- Lead sponsor
- Circassia Limited
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 1,408 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2012
- U.S. locations
- 52
- States / cities
- Rolling Hills Estates, California • Colorado Springs, Colorado • Denver, Colorado + 49 more
- Conditions
- Conjunctivitis, Allergic
- Interventions
- Olopatadine, Fluticasone, Saline, Artificial tears
- Drug
- Lead sponsor
- Greiner, Jack V., OD DO PhD
- Individual
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- North Andover, Massachusetts
- Conditions
- Allergic Rhinitis Due to Grass Pollens
- Interventions
- 300 IR, Placebo
- Drug
- Lead sponsor
- Stallergenes Greer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 473 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 19
- States / cities
- Normal, Illinois • Lexington, Kentucky • Owensboro, Kentucky + 16 more
- Conditions
- Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis, Allergic Rhinoconjunctivitis
- Interventions
- Intra-lymphatic allergenic extract, Intra-lymphatic placebo
- Biological
- Lead sponsor
- Christopher Thompson, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 3
- States / cities
- Austin, Texas • Grapevine, Texas • San Antonio, Texas
- Conditions
- Allergic Rhinoconjunctivitis
- Interventions
- CryJ2-DNA-LAMP plasmid vaccine by intramuscular injection
- Biological
- Lead sponsor
- Immunomic Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 63 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Honolulu, Hawaii
- Conditions
- Hay Fever
- Interventions
- topical nasal rEV131
- Drug
- Lead sponsor
- Evolutec Group
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005
- U.S. locations
- 2
- States / cities
- San Antonio, Texas
- Conditions
- Allergic Rhinitis
- Interventions
- Standardized Ragweed Allergenic Extract, Placebo
- Biological
- Lead sponsor
- Greer Laboratories
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 430 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 30
- States / cities
- Normal, Illinois • Evansville, Indiana • Iowa City, Iowa + 23 more
- Conditions
- Allergy
- Interventions
- ALK Ragweed Tablet
- Biological
- Lead sponsor
- ALK-Abelló A/S
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Allergic Rhinoconjunctivitis
- Interventions
- CryJ2-DNA-LAMP plasmid vaccine by intramuscular injection
- Biological
- Lead sponsor
- Immunomic Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 63 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Honolulu, Hawaii
- Conditions
- Seasonal Allergic Rhinitis, Hay Fever, Allergic Conjunctivitis, Hypersensitivity
- Interventions
- Bilastine, Placebo
- Drug
- Lead sponsor
- Faes Farma, S.A.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 805 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 13
- States / cities
- Oklahoma City, Oklahoma • Austin, Texas • Kerrville, Texas + 2 more
- Conditions
- Allergic Rhinoconjunctivitis
- Interventions
- Not listed
- Lead sponsor
- ORA, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo comparator, Grass MATA MPL
- Biological
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 4
- States / cities
- Edison, New Jersey • Ocean City, New Jersey • Springfield, New Jersey + 1 more
- Conditions
- Allergic Conjunctivitis, Rhinoconjunctivitis
- Interventions
- Alcaftadine
- Drug
- Lead sponsor
- Starx Research Center, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013
- U.S. locations
- 2
- States / cities
- Edison, New Jersey • Springfield, New Jersey
- Conditions
- Ragweed Allergy
- Interventions
- Not listed
- Lead sponsor
- Circassia Limited
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 10
- States / cities
- Owensboro, Kentucky • Minneapolis, Minnesota • Plymouth, Minnesota + 7 more
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- PQ Grass, Active Placebo, Standard Placebo
- Biological · Drug
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 8
- States / cities
- Lexington, Kentucky • White Marsh, Maryland • Ocean Township, New Jersey + 5 more
- Conditions
- Allergic Rhinoconjunctivitis
- Interventions
- Not listed
- Lead sponsor
- ORA, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Allergy
- Interventions
- Grazax
- Drug
- Lead sponsor
- ALK-Abelló A/S
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 329 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Allergic Rhinitis
- Interventions
- Grass MATA MPL 10200, Grass MATA MPL 18200, Placebo
- Biological
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Neptune City, New Jersey • Newark, New Jersey